Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Stryker Corp (SYK)

Stryker Corp (SYK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Stryker Corp 1941 Stryker Way Portage MI 49002 USA

www.strykercorp.com Employees: 53,000 P: 269-385-2600 F: 269-385-1062

Sector:

Medical

Description:

Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic'products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg'products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.

Key Statistics

Overview:

Market Capitalization, $K 139,948,064
Enterprise Value, $K 149,893,056
Shares Outstanding, K 382,424
Annual Sales, $ 22,595 M
Annual Net Income, $ 2,993 M
Last Quarter Sales, $ 6,057 M
Last Quarter Net Income, $ 859,000 K
EBIT, $ 5,342 M
EBITDA, $ 6,392 M
60-Month Beta 0.89
% of Insider Shareholders 5.90%
% of Institutional Shareholders 77.09%
Float, K 359,861
% Float 94.10%
Short Volume Ratio 0.51

Growth:

1-Year Return -6.52%
3-Year Return 48.94%
5-Year Return 56.91%
5-Year Revenue Growth 51.81%
5-Year Earnings Growth 47.58%
5-Year Dividend Growth 51.40%

Per-Share Information:

Most Recent Earnings 3.19 on 10/30/25
Next Earnings Date 01/27/26
Earnings Per Share ttm 13.17
EPS Growth vs. Prev Qtr 1.92%
EPS Growth vs. Prev Year 11.15%
Annual Dividend & Yield 3.36 (0.92%)
Annual Dividend & Yield (Fwd) 3.36 (0.92%)
Most Recent Dividend 0.840 on 09/30/25
Next Ex-Dividends Date 09/30/25
Dividend Payable Date 10/31/25
Dividend Payout Ratio 25.23%
Most Recent Split 2-1 on 05/17/04

SYK Ratios

Ratio
Price/Earnings ttm 27.84
Price/Earnings forward 27.06
Price/Earnings to Growth 2.60
Return-on-Equity % 24.07%
Return-on-Assets % 11.16%
Profit Margin % 13.25%
Debt/Equity 0.76
Price/Sales 6.21
Price/Cash Flow 24.31
Price/Book 6.44
Book Value/Share 56.97
Interest Coverage -1.40

SYK Dividends

Date Value
09/30/25 $0.8400
06/30/25 $0.8400
03/31/25 $0.8400
12/31/24 $0.8400
09/30/24 $0.8000
06/28/24 $0.8000
03/27/24 $0.8000
12/28/23 $0.8000
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar